Centaurus Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$459K Sell
1,187
-191
-14% -$70.8K 0.02% 600
2026
Q1
$403K Sell
1,378
-322
-19% -$106K 0.02% 588
2025
Q4
$596K Sell
1,700
-1,716
-50% -$580K 0.03% 480
2025
Q3
$1.1M Buy
3,416
+1,349
+65% +$420K 0.05% 307
2025
Q2
$804K Sell
2,067
-313
-13% -$126K 0.05% 344
2025
Q1
$1.03M Buy
2,380
+131
+6% +$52.6K 0.06% 273
2024
Q4
$830K Buy
2,249
+772
+52% +$323K 0.05% 304
2024
Q3
$768K Buy
1,477
+559
+61% +$299K 0.05% 321
2024
Q2
$498K Buy
918
+368
+67% +$195K 0.03% 390
2024
Q1
$285K Buy
550
+259
+89% +$129K 0.02% 515
2023
Q4
$137K Buy
+291
New +$135K 0.01% 683
2023
Q2
Sell
-760
Closed -$349K 800
2023
Q1
$349K Buy
+760
New +$362K 0.03% 501
2022
Q4
Sell
-661
Closed -$300K 856
2022
Q3
$300K Buy
+661
New +$316K 0.03% 486
2020
Q1
Sell
-2,065
Closed -$624K 550
2019
Q4
$624K Buy
+2,065
New +$568K 0.09% 260
2018
Q3
Sell
-597
Closed -$142K 940
2018
Q2
$142K Buy
+597
New +$138K 0.02% 602

Other funds holding ELV

Centaurus Financial's ELV Position: Q2 2026 in Review

Centaurus Financial reduced its Elevance Health (ELV) stake by 14% in Q2 2026, selling an estimated $70.8K and leaving 1,187 shares worth $459K. The position accounts for 0.02% of the portfolio, ranked #600.

Centaurus Financial first reported a position in ELV in Q2 2018 and has held it in 15 quarters since. The position peaked at $1.1M in Q3 2025. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Centaurus Financial held 1,187 shares of Elevance Health worth $459K as of Q2 2026.
  • Centaurus Financial sold 191 Elevance Health shares in Q2 2026, an estimated $70.8K.
  • Elevance Health made up 0.02% of Centaurus Financial's portfolio in Q2 2026, its #600 holding.
  • Centaurus Financial first reported a position in Elevance Health in Q2 2018 and has held it in 15 quarters since.
  • Centaurus Financial's Elevance Health position peaked at $1.1M in Q3 2025.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.